fda approved glp-1 receptor agonists list of and pending medications 5 GLP-1 trends to expect

Keywords GLP-1 Agonists SGLT-2 Inhibitors Diabetes Mellitus Chronic Kidney Disease Liver Transplantation Introduction Despite the life-saving intervention of liver transplantation for patients with ESLD (end-stage liver disease), the success of transplantation is compromised often by post-transplant complications, particularly diabetes mellitus and chronic kidney disease (CKD)

News Release: Lilly's oral GLP-1, orforglipron, demonstrated statistically significant efficacy results and a safety profile consistent with injectable GLP-1 medicines in successful Phase 3 trial

Lee YS, Shin S, Shigihara T, Hahm E, Liu MJ, Han J, et al

In the U.S., GLP-1 prescriptions more than doubled in just 18 months, topping nine million by early 2024

Among adults receiving 36 mg orforglipron, 50.1% lost at least 10% of their body weight at 72 weeks